The UK's Department for Business and Trade is delighted to bring a delegation of innovative UK companies. Find out more about the companies below and click on a logo to open the company's website.

CyberLiver uses AI, connected devices and behaviour change techniques for the early detection and management of liver diseases. Holding both FDA Breakthrough Device status and UKCA Class IIa certification, we collaborate with NHS hospitals in the UK and the renowned Cedars-Sinai Hospital in the US. We are proud finalists in the Digital Health Hub Foundation's Digital Health Awards, 2023 at HLTH. 

Better outcomes, fewer admissions, and less staff time with automated clinical conversations via text.  A spin-out from the UK’s NHS, now successfully expanding in US.

ieso is a digital healthcare company with deep scientific and technical expertise that is primed to revolutionize mental health.Our insights from our globally unique dataset, having cared for more than 120,000 patients in the UK NHS on our typed teletherapy platform, are enabling the development of novel digital products that provide clinical-grade mental healthcare at a massive scale.

Lindus Health is an anti-CRO running radically faster and more reliable clinical trials for HLTH pioneers. We have helped over 80 Sponsors run entire clinical studies up to 3x faster than typical CROs.

Pangaea’s product platform helps clinicians characterize patients for finding and connecting to more undiagnosed and miscoded patients for 7,000 conditions, thus improving outcomes, revenues and screening, in a privacy-preserving manner. Pangaea was awarded UK’s ‘Digital Solution of the Year’ 2023 and Microsoft’s top tier partnership, which is enabling Pangaea’s product to be scaled across 140,000 healthcare providers globally. Its founders have raised over $200M through their research and are advised by Lord Prior (former chairman, NHS England) and Andy Palmer (former CIO, Novartis). 

Cyted is a pioneering health company that creates innovative upper GI diagnostics to detect disease early and improve health. Our minimally-invasive diagnostic solutions and biomarker discovery platform are opening up opportunities for new testing.

Fora Health has identified that care teams often lack the time / tools to support patient choice and that patients are frequently not engaged with their care. Understanding these issues, we engage patients and care teams in value-based shared discussions and decision-making. US pilots to date include shared decision-making for patients with depression and with rare diseases.

inicio uses a unique technology stack to achieve successful EHR integration and the provision of intelligent automation, augmenting human workforce with a suite of digital workers. inicio has delivered over 300 automations across the NHS saving hundreds of hours of workforce time and is perfectly placed to support you on your automation journey to realise savings whilst maximising productivity. 

At ORCHA, we bridge the gap between the demand for health apps and limited healthcare provider recommendations. Our mission is to empower Healthcare System Providers with the infrastructure needed for safe and scalable digital health integration.

Panakeia’s proprietary software provides multi-omic biomarker information (genomic, protein, RNA, metabolite changes) in minutes instead of days/weeks. Panakeia does this by rapid analysis by analysing images of H&E-stained tissue, without needing wet-lab assays. Panakeia can save lives by accelerating drug development and enabling 1-day turnaround time for treatment decision-making.